Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialPhilip C. Prorok, John K. Gohagan, Marsha Hasson et al.|Controlled Clinical Trials|2000Cited by 1k
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trialBrian G. Feagan, Laurent Peyrin‐Biroulet, Silvio Danese et al.|The Lancet|2021Cited by 452
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac DiseaseJoseph A. Murray, Richard A. Krause, Ciarán P. Kelly et al.|Gastroenterology|2016Cited by 137
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction StudyLaurent Peyrin‐Biroulet, Toshimitsu Fujii, Jessica R. Allegretti et al.|Gastroenterology|2023Cited by 97